#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3361954	B	Agonist activity at human TAS2R16 expressed in U2OS cells by summary (Abse5) assay	Homo sapiens	1		cell-based format	Scientific Literature
2.	ALA3361955	B	Antagonist activity at human TAS2R16 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assay	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA4346431	F	Antagonist activity at recombinant human TAS2R16 transiently expressed in HEK293T co-expressing Galpha16gust44 assessed as inhibition of salicin-induced intracellular calcium level by measuring remaining activity at 25 uM by fluo-4AM dye based FLIPR assay relative to control	Homo sapiens	2		cell-based format	Scientific Literature
4.	ALA4417701	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 10 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
5.	ALA4417702	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 5 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
6.	ALA4417703	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 2.5 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
7.	ALA4417704	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 1.25 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
8.	ALA4417705	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 0.625 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
9.	ALA4417706	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 0.3125 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
10.	ALA4417707	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 0.1563 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
11.	ALA4417708	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 0.0781 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
12.	ALA4417709	F	Antagonist activity at full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 25 uM in presence of 0.0391 mM phenyl-beta-glucopyranoside by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
13.	ALA4417710	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 10 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
14.	ALA4417711	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 5 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
15.	ALA4417712	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 2.5 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
16.	ALA4417713	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 1.25 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
17.	ALA4417714	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 0.625 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
18.	ALA4417715	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 0.3125 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
19.	ALA4417716	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 0.1563 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data
20.	ALA4417717	F	Activation of full-length human TAS2R16 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 0.0781 mM by Fluo-4 dye based FLIPR assay	Homo sapiens	1		cell-based format	Patent Bioactivity Data